[ad_1]
The post is based on research conducted by more than 7,000. medical personnel who had been vaccinated with this vaccine at the Shebah Medical Center in Israel. Experts have noted that its efficiency is 85 percent. occurred 15-28 days after injection.
Pfizer distributed a report highlighting that it was analyzing data from Israel and other countries to understand the true efficacy of its COVID-19 vaccines.
The Lancet article was published one day after Canadian medical experts proposed to postpone vaccinations with a second dose of the Pfizer / BioNTech vaccine, given the relatively strong immune response after the first injection, to increase the number of people vaccinated. .
The New England Journal of Medicine reported that researchers from the British Columbia Center for Disease Control and the National Institute of Public Health of Quebec have found that the first dose of Pfizer / BioNTech COVID-19 could reach 92.6 per hundred. Thus, at this stage, to broaden the scope of vaccination in the general population, it is sufficient to administer only the first dose and the second dose later, when the vaccine supply increases.
[ad_2]
